The tumor/NAT pir-hsa-216911 ratio was significantly higher in patients with steatohepatitis (Fig. 7B), indicating that pir-hsa-216911 deregulation was correlated with steatohepatitis and fat liver disease. The gene discussed is BRD2; the disease is neoplasm.